J
José C. Pascual
Publications - 71
Citations - 1253
José C. Pascual is an academic researcher. The author has contributed to research in topics: Hidradenitis suppurativa & Skin cancer. The author has an hindex of 17, co-authored 69 publications receiving 930 citations.
Papers
More filters
Journal ArticleDOI
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Amit Garg,Erica Neuren,Denny Cha,Joslyn S. Kirby,John R. Ingram,Gregor B.E. Jemec,Solveig Esmann,L. Thorlacius,B. Villumsen,Véronique Del Marmol,Aude Nassif,Maïa Delage,Thrasyvoulos Tzellos,Dagfinn Moseng,Øystein Grimstad,Haley B. Naik,Robert G. Micheletti,S. Guilbault,Angie Parks Miller,Iltefat H. Hamzavi,Hessel H. van der Zee,Errol P. Prens,Naomi Kappe,Christine B. Ardon,Brian Kirby,R. Hughes,Christos C. Zouboulis,Georgios Nikolakis,Falk G. Bechara,Lukasz Matusiak,Jacek C Szepietowski,Amelia Głowaczewska,Saxon D Smith,Noah Goldfarb,Steven Daveluy,Christina Avgoustou,Evangelos J. Giamarellos-Bourboulis,Steven R. Cohen,Yssra Soliman,Elena Gonzalez Brant,Oleg E. Akilov,Christopher Sayed,Jerry Tan,Afsaneh Alavi,Michelle A. Lowes,José C. Pascual,Hassan Riad,Shani Fisher,Arnon D. Cohen,So Yeon Paek,Barry I. Resnik,Qiang Ju,Lanqi Wang,Andrew Strunk +53 more
TL;DR: HS patients have identified several critical unmet needs that will require stakeholder collaboration to meaningfully address in multidisciplinary care, treatment, research, advocacy, and philanthropy.
Journal ArticleDOI
Cutaneous Drug Eruption to Infliximab: Report of 4 Cases With an Interface Dermatitis Pattern
Gloria Vergara,Juan Francisco Silvestre,Isabel Betlloch,Paloma Vela,M. P. Albares,José C. Pascual +5 more
Journal ArticleDOI
Trichomegaly following treatment with gefitinib (ZD1839).
TL;DR: The first report of a patient with ALHE successfully treated with imiquimod is reported, suggesting its use in other cutaneous vascular tumours.
Journal ArticleDOI
What causes hidradenitis suppurativa ?-15 years after
Christos C. Zouboulis,Farida Benhadou,Angel As Byrd,Nisha Ns Chandran,Evangelos J. Giamarellos-Bourboulis,Gabriella Fabbrocini,John Jw Frew,Hideki Fujita,Marcos Ma González-López,Philippe Guillem,Wayne Wpf Gulliver,Iltefat H. Hamzavi,Yildiz Hayran,Barbara Horváth,Sophie Hue,Robert Re Hunger,John R. Ingram,Gregor B.E. Jemec,Qiang Ju,Alexa Ab Kimball,Joslyn S. Kirby,Maria Mp Konstantinou,Michelle Ma Lowes,Amanda S. MacLeod,Antonio Martorell,Angelo V. Marzano,Angelo V. Marzano,Łukasz Matusiak,Aude Nassif,Elena Nikiphorou,Georgios Nikolakis,Andre Nogueira da Costa,Martin M. Okun,Lauren Lav Orenstein,José C. Pascual,Ralf Paus,Benjamin Perin,Errol P. Prens,Till Ta Röhn,Andrea Szegedi,Jacek C Szepietowski,Thrasyvoulos Tzellos,Baoxi Wang,Hessel H. van der Zee +43 more
TL;DR: This anniversary article of 43 research‐performing authors from all around the globe in the official journal of the European Hidradenitis Suppurativa Foundation e.V. summarizes the evidence of the intense HS clinical and experimental research during the last 15 years in all aspects of the disease.
Journal ArticleDOI
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
L. Thorlacius,L. Thorlacius,Amit Garg,Peter Theut Riis,Sabrina Mai Nielsen,Vincenzo Bettoli,John R. Ingram,V. Del Marmol,Lukasz Matusiak,José C. Pascual,Jean Revuz,Karin Sartorius,Thrasyvoulos Tzellos,H.H. van der Zee,Christos C. Zouboulis,Ditte Marie Saunte,Alice B. Gottlieb,Robin Christensen,Robin Christensen,Gregor B.E. Jemec +19 more
TL;DR: Monitoring disease activity over time is a prerequisite for clinical practice and research and valid and reliable outcome measurement instruments (OMIs) and staging systems provide researchers and clinicians with benchmark tools to assess the primary and secondary outcomes of interventional trials.